The disclosure provides for compositions and methods for treating neurodegenerative and cardiovascular disease in a subject. The compositions and methods include delivering a nucleic acid molecule encoding VGF or a peptide thereof to a subject. The disclosure further provides methods for the diagnosis of neurodegenerative and cardiovascular disease.
